-
The 3D evolution of glioma cell populations
Study
EGAS00001003710
-
Characterization of patient-derived xenograft models of myxoid liposarcoma either sentitive or resistant to trabectedin
Study
EGAS00001003715
-
Whole genome sequencing of adult glioblastoma nuclei
Study
EGAS00001005256
-
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif
Study
EGAS00001003719
-
Cancer and germline exomes consisting of FASTQ paired-end reads from melanoma and lung cancer samples
Study
EGAS00001003723
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Study
EGAS00001000510
-
DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load
Study
EGAS00001003731
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases
Study
EGAS00001000709
-
Genomics_of_acral_lentiginous_melanoma
Study
EGAS00001003740
-
Targeted_sequencing_of_cylindroma_patients
Study
EGAS00001002708
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts
Study
EGAS00001003747
-
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation
Study
EGAS00001003750
-
Study of pediatric hepatocellular carcinoma caused by bile salt export pump deficiency
Study
EGAS00001000749
-
Subtype specific progression from DCIS to invasive breast cancer
Study
EGAS00001001866
-
Mongolia Western HCC
Study
EGAS00001005364
-
NRG1 Fusions in KRAS Wild-type Pancreatic Cancer (H021)
Study
EGAS00001002759
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma - 30 whole exomes
Study
EGAS00001001892
-
Targeted panel data for newly diagnosed myeloma patients.
Study
EGAS00001002859
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
RNAseq of 76 samples from Uveal Melanoma tumors
Study
EGAS00001002932
-
Genomics_of_acral_lentiginous_melanoma___RNAseq
Study
EGAS00001003758
-
The_contribution_of_POT1_variants_to_sporadic_melanoma_development
Study
EGAS00001001964
-
Identification of recurrent mutations in Cushing’s disease
Study
EGAS00001003029
-
IMCISION DNAseq
Study
EGAS00001005466
-
Whole genome and whole transcriptome sequencing of Hepatosplenic T Cell Lymphoma tumor.
Study
EGAS00001003775
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
Sequencing_melanoma_germlines
Study
EGAS00001002081
-
Melanoma_brain_metastases
Study
EGAS00001002107
-
Single-cell RNA-seq data of the tumor microenvironment of lymphocyte-rich Hodgkin lymphoma and other Hodgkin lymphoma subtypes
Study
EGAS00001005541
-
RNA sequencing CYLD cutaneous syndrome
Study
EGAS00001003841
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
A single-cell atlas of human glioma
Study
EGAS00001003845
-
Neuroblastoma sequencing data
Study
EGAS00001005602
-
Whole-transcriptome sequencing of hepatocellular carcinoma biopsies (TACE study)
Study
EGAS00001005558
-
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.
Study
EGAS00001002334
-
UK renal cancer samples genotyped on Illumina OmniExpress BeadChip
Study
EGAS00001002336
-
Single cell phenotypic profiling of 27 DLBCL cases reveals marked inter- and intra-tumoral heterogeneity
Study
EGAS00001003860
-
Pre-neoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Study
EGAS00001005656
-
WGS of T-cell and NK-cell lymphoma for ICGC (NKTL-SG)
Study
EGAS00001002398
-
Epigenome wide DNA methylation assay of gingivo-buccal oral squamous cell carcinoma using single base resolution high throughput array
Study
EGAS00001003896
-
Exome sequencing of pseudomyxoma peritonei
Study
EGAS00001002418
-
The genomic landscape of germinal center derived B-cell lymphomas other than follicular, diffuse-large B-cell and Burkitt lymphom
Study
EGAS00001002422
-
Cell fate mapping of human glioblastoma reveals an invariant stem cell hierarchy pre- and post-treatment
Study
EGAS00001002424
-
A combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancer
Study
EGAS00001002444
-
Mutational signatures of aflatoxin
Study
EGAS00001002490
-
Genomic Profiling Reveals Spatial Intra-tumour Heterogeneity in Follicular Lymphoma
Study
EGAS00001002492
-
Analysis of enhancer-promoter connectivity alterations
Study
EGAS00001007411
-
Sampling of multi-centric lower grade glioma influences management and provides insight into gliomagenesis
Study
EGAS00001002495
-
Transcriptome sequencing of intravenous leiomyomatosis and uterine myoma
Study
EGAS00001002504
-
ATRX mutant neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal differentiation.
Study
EGAS00001002507
-
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma
Study
EGAS00001002517
-
Genomes of Relapsing Neuroblastoma
Study
EGAS00001001387
-
Whole-genome bisulfite sequencing analysis of low-grade astrocytomas in the ICGC PedBrain Tumor Project
Study
EGAS00001004019
-
SCC tumor sequencing
Study
EGAS00001003988
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
Comparative genomics research for Chinese colorectal cancer
Study
EGAS00001002607
-
Somatic_mutation_and_clonal_evolution_in_the_human_pancreas___WGS
Study
EGAS00001002626
-
Ultra-Fast Patient-Derived Xenografts Identify Functional and Spatial Tumour Heterogeneities that Drive Therapeutic Resistance
Study
EGAS00001002627
-
HDAC inhibitors in synovial sarcoma cells
Study
EGAS00001002637
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
The identification of genetic vulnerabilities in head and neck cancers for the development of novel treatments.
Study
EGAS00001002682
-
Alternative splicing isoforms in patient-derived hepatocellular carcinoma cells
Study
EGAS00001002697
-
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
Study
EGAS00001005786
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_DNA
Study
EGAS00001005799
-
Defective Homologous Recombination DNA Repair as Therapeutic Target in Advanced-Stage Chordoma (HIPO_021)
Study
EGAS00001002720
-
Single-cell RNA sequencing of 22 Hodgkin lymphoma tumors and 5 reactive lymph nodes
Study
EGAS00001004085
-
Exon4-mutations in KRAS Affect MEK-ERK and Pi3K-AKT Signaling in Multiple Myeloma
Study
EGAS00001004110
-
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Study
EGAS00001002757
-
An integrated molecular study of 20 hepatoblastoma pairs using whole genome sequencing and RNA sequencing
Study
EGAS00001002772
-
Germline SDHB-inactivating mutation in gastric spindle cell sarcoma (HIPO-021)
Study
EGAS00001004277
-
TRACERx Renal 100
Study
EGAS00001002793
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_adenocarcinoma
Study
EGAS00001003702
-
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
Study
EGAS00001002812
-
THE GENOMIC LANDSCAPE OF ACTINIC KERATOSIS
Study
EGAS00001004243
-
Genomic landscape and PD-1 blockade in Natural-killer/T cell lymphoma
Study
EGAS00001003828
-
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Study
EGAS00001001632
-
Sequencing of an organoid biobank for childhood soft tissue sarcoma.
Study
EGAS00001005912
-
Whole genome bisulfite sequencing on 10 multiple myeloma cases
Study
EGAS00001004346
-
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell RCC -- CA209-010
Study
EGAS00001004291
-
Molecular profiling of metastatic uveal melanoma
Study
EGAS00001004296
-
WES of melanoma tumors treated with combined immune checkpoint blockade
Study
EGAS00001003857
-
VIKING Health Study - Shetland
Study
EGAS00001003872
-
Small_molecule_inhibitors_in_melanoma___Kenski___Kong___WES
Study
EGAS00001002863
-
Multi-omics profiling of paired primary and recurrent glioblastoma patient tissues
Study
EGAS00001004345
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
RNA-seq of Liver Cancer
Study
EGAS00001002879
-
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Study
EGAS00001003953
-
Whole Genome Sequencing of HCC
Study
EGAS00001002888
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
SCC ctDNA sequencing
Study
EGAS00001003987
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
A Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling
Study
EGAS00001004018
-
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Study
EGAS00001004550
-
SS18-SSX-mediated hijacking of BAF complexes drives synovial sarcoma
Study
EGAS00001002920
-
Leeds Melanoma Cohort (LMC) gene expression study
Study
EGAS00001002922
-
RNA-seq of Ewing sarcoma tumors (ICGC)
Study
EGAS00001003333
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426